EBIRIOS - Exenatide and Basal Insulins Use in the Real Setting: an Italian Observational Study in Patients With Type 2 Diabetes and Secondary Failure of Oral Antihyperglycemic Treatment.

Trial Profile

EBIRIOS - Exenatide and Basal Insulins Use in the Real Setting: an Italian Observational Study in Patients With Type 2 Diabetes and Secondary Failure of Oral Antihyperglycemic Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jul 2014

At a glance

  • Drugs Exenatide; Insulin; Insulin detemir; Insulin glargine; Insulin neutral protamine lispro
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms EBIRIOS
  • Sponsors AstraZeneca
  • Most Recent Events

    • 27 Nov 2013 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 07 Mar 2012 Planned end date changed from 1 Mar 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
    • 16 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top